Can brain natriuretic peptide be used to diagnose and manage patients with diastolic heart failure?

Nature Clinical Practice Cardiovascular Medicine

Volumn 3, Issue 8, 2006, Pages 418-419

  Pieske, Burkert ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL BRAIN NATRIURETIC PROPEPTIDE; BRAIN NATRIURETIC PEPTIDE; NATRIURETIC FACTOR; UNCLASSIFIED DRUG;

CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIASTOLE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; EXERCISE TEST; HEART ATRIUM ENLARGEMENT; HEART CATHETERIZATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE WALL; HEART MUSCLE ISCHEMIA; HUMAN; MORBIDITY; MORTALITY; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; SHORT SURVEY; SIGNAL TRANSDUCTION;

EID: 33746638724     PISSN: 17434297     EISSN: 17434300     Source Type: Journal    
DOI: 10.1038/ncpcardio0606     Document Type: Short Survey

References (5)

1. Hunt SA et al. (2005) ACC/AHA guidelines update for the diagnosis and management of chronic heart failure in the adult. Circulation 112: e154-e235
2. Dahlstöm U (2004) Can natriuretic peptides be used for the diagnosis of diastolic heart failure? Eur J Heart Fail 6: 281-287
3. Hartmann F et al. (2004) Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure. Circulation 110: 1780-1786
4. 2+-ATPase expression. Circulation, in press
5. Valle R et al. (2005) B-type natriuretic peptide can predict the medium-term risk in patients with acute heart failure and preserved systolic function. J Card Fail 11: 498-503